Four monotypic genera of the tribe Siculodini are revised and adults and their genitalia illustrated for each sexes. Hepialodes Guenée, 1858, Iza Walker, 1865 and Loxiorhiza Warren, 1904 have been initially described to incorporate just one species every they usually haven’t been topic to taxonomic revision since that point. From our research, Meskea Grote, 1877, beforehand with two species, turns into the monobasic Meskea horror Dyar, 1913 syn. nov. of Meskea dyspteraria Grote, 1877. These genera happen in South America, and of these solely Meskea extends to the southern North America. Lectotypes are designated for Hepialodes follicula Guenée, 1858, Siculodes nubecula Guenée
1858 and Zeuzerodes (Siculodes) cervinalis Pagenstecher, 1892. The identities of 5 subspecies of Pleurota bicostella (Clerck, 1759) are studied, and every is raised from subspecies to species: P. andalusica Back, 1973, stat. nov.; P. aragonella Chrétien, 1925, stat. rev.; P. asiatica Back, 1973, stat. nov.; P. illucidella Chrétien, 1915, stat. rev.; P. lepigrei Lucas, 1937, stat. rev. Nine new Pleurota species which all belong to the P. bicostella species group are described: P. agadirensis Tabell, sp. nov.; P. aprilella Tabell, sp. n.; P. karsholti Tabell, sp. nov.; P. kullbergi Tabell, sp. nov.; P. monochroma Tabell, sp. nov.; P. murina Tabell, sp. nov.; P. paragallicella Tabell, sp. nov; P. phaeolepida Tabell, sp. nov., all from Morocco; and P. dalilae Tabell, sp. nov. from Tunisia.
Adult women and men, and their genitalia are illustrated. DNA barcodes of the aforementioned species are in contrast with these of all different Pleurotinae obtainable to us in the BOLD database. Each of the introduced and barcoded species has a novel BIN (Barcode Index Number). The genus Nola was established with the western Palaearctic species Noctua cucullatella (Linnaeus, 1758) described from Austria as its sort species. Nola happens in all continents besides the Antarctica and incorporates greater than 200 legitimate Eurasian and North African taxa (László et al., 2014).
The genus Nola could be simply distinguished from different genera of Nolinae with the distinctive options as the degenerate uncus, the divided valva with the ventral valval lobe bearing the harpe and a curved carina course of in male genitalia. In our current survey, we report a brand new species Nola senmuzhaensis sp. nov. and a brand new report of Nola sikkima (Moore, 1888) from Tibet, China. Adults and genitalia are illustrated. The sort specimens are deposited in Southwest University of Science and Technology (SWUST).
Taxonomic composition and monophyly of the genus Magnificus (Lepidoptera: Hepialoidea: Hepialidae)
The genus Magnificus Yan, 2000 was initially established to incorporate M. jiuzhiensis Yan, 2000 and M. zhiduoensis Yan, 2000. Here we additionally embody the species M. bouvieri (Oberthür, 1913) comb. n., M. dirschi (Bang-Haas, 1939) comb. n., M. miniatus (Chu Wang, 1985a) comb. n., M. regius (Staudinger, 1896) comb. n., and M. roseus (Oberthür, 1911) comb. n. Monophyly of Magnificus is supported by the shared presence of a novel form of the tergosternal sclerite in the anterio-abdominal area and pseudoteguminal arm in the male genitalia. We additionally present proof for the inclusion of Magnificus and the northern Eurasian genera Hepialus Fabricius, Pharmacis Hübner
Triodia Hübner and Zenophassus Tindale as members of a bigger monophyletic group supported by the shared presence in the male genitalia of a deep U-shaped medial notch in the posterior margin of the saccus and an expanded triangular flange at the lateral corners of the notch. The reciprocally allopatric distribution of Magnificus and its possible sister group is per every originating regionally by vicariance over completely different elements of a widespread ancestral vary.
This divergence could also be the end result of tectonic uplift in central Asia. Two Lophocampa species beforehand identified solely by females are paired with morphologically extremely completely different male specimens. This pairing was initiated after the discovery of a mosaic gynandromorph specimen after which confirmed utilizing the mitochondrial COI gene (the so-called DNA barcode). Following the discovery of a labeling error by Rothschild throughout the unique description of two species, two recombinations are proposed. Pairs for every species are illustrated and the male specimens are described for the first time.
Minoa lutea Schwingenschuss, 1954 (Lepidoptera: Geometridae: Larentiinae) acknowledged as bona species
Three species of the genus Frisilia Walker, 1864 are described as new: Frisilia basistricta sp. nov., F. motuoensis sp. nov. and F. trisigna sp. nov.; F. sulcata is newly recorded in China. Images of adults and genitalia for all newly described species, a key to the Chinese species, a guidelines of the worldwide Frisilia species and a distribution map displaying the locality of the Chinese Frisilia species are given. The taxon Minoa murinata var. monochroaria Herrich-Schäffer, 1848 is downgraded from subspecies rank to synonymy of M. murinata.
IFN-omega Recombinant Protein |
40-519-01mg |
ProSci |
0.1 mg |
EUR 437.1 |
Description: IFN-omega is a type I interferon, which can be induced by virus-infected leukocytes. Members of the type I interferon family, which includes IFN-a, IFN-B, and IFN-w, signal through IFNAR-1/IFNAR-2 receptor complex, and exert anti-viral and anti-proliferative activities. IFN-omega exhibits about 75% sequence homology with IFN-a, and contains two conserved disulfide bonds, which are necessary for full biological activity. Recombinant Human IFN-omega is a 19.9 kDa protein consisting of 172 amino acid residues. |
IFNW1 Interferon -Omega 1 Human Recombinant Protein |
PROTP05000 |
BosterBio |
Regular: 100ug |
EUR 380.4 |
Description: Interferon-Omega 1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 172 amino acids and having a molecular mass of 19.9kDa.;The Interferon-Omega 1 is purified by proprietary chromatographic techniques. |
Active Recombinant Human Interferon omega-1/IFNW1 Protein |
RP01752 |
Abclonal |
20μg |
EUR 45.5 |
|
Recombinant Human Interferon omega-1 protein(IFNW1) (Active) |
AP73435 |
SAB |
1mg |
EUR 1627 |
|
Recombinant Human IFN-Omega Protein |
PROTP05000-1 |
BosterBio |
100ug |
EUR 380.4 |
Description: IFN-ω is a type I interferon, which can be induced by virus-infected leukocytes. Members of the type I interferon family, which includes IFN-α, IFN-β, and IFN-ω, signal through IFNAR-1/IFNAR-2 receptor complex, and exert antiviral and antiproliferative activities. IFN-ω exhibits about 75% sequence homology with IFN-α, and contains two conserved disulfide bonds, which are necessary for full biological activity. Recombinant Human IFN-ω is a 19.9 kDa protein consisting of 172 amino acid residues. |
Recombinant Human Interferon omega-1 protein (IFNW1), partial (Active) |
CSB-AP002821HU |
Cusabio |
8488 mg |
Ask for price |
OPCA03546-1MG - Omega-5 gliadinImported Recombinant Protein |
OPCA03546-1MG |
Aviva Systems Biology |
1mg |
EUR 1977 |
|
OPCA03546-100UG - Omega-5 gliadinImported Recombinant Protein |
OPCA03546-100UG |
Aviva Systems Biology |
100ug |
EUR 586 |
|
OPCA03546-20UG - Omega-5 gliadinImported Recombinant Protein |
OPCA03546-20UG |
Aviva Systems Biology |
20ug |
EUR 400 |
|
Human IFN-omega Recombinant Protein Lyophilized |
IHUIFNORLY20UG |
Innovative research |
each |
EUR 341 |
|
Description: Human IFN-omega Recombinant Protein Lyophilized |
OPCA03130-1MG - Omega-hexatoxin-Hv1a Recombinant Protein |
OPCA03130-1MG |
Aviva Systems Biology |
1mg |
EUR 1977 |
|
OPCA03130-20UG - Omega-hexatoxin-Hv1a Recombinant Protein |
OPCA03130-20UG |
Aviva Systems Biology |
20ug |
EUR 400 |
|
OPCA03130-100UG - Omega-hexatoxin-Hv1a Recombinant Protein |
OPCA03130-100UG |
Aviva Systems Biology |
100ug |
EUR 586 |
|
Recombinant Bovine Interferon omega-1 (IFNW1) |
CSB-EP011061BO |
Cusabio |
1450 mg |
Ask for price |
Recombinant Bovine Interferon omega-1(IFNW1) |
AP77141 |
SAB |
1mg |
EUR 2826 |
|
GSTO2 Glutathione S-Transferase Omega 2 Human Recombinant Protein |
PROTQ9H4Y5 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: GSTO2 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 266 amino acids (1-243) and having a molecular mass of 30.6kDa.;GSTO2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
GSTO1 Glutathione S-Transferase Omega 1 Human Recombinant Protein |
PROTP78417 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: GSTO1 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 241 amino acids fragment (1-241) having a Mw of 32.1 kDa.;GSTO1 is fused with an amino-terminal hexahistidine tag having a total Mw of 36kDa and purified by proprietary chromatographic techniques. |
GSTO1 Glutathione S-Transferase Omega 1 Mutant Human Recombinant Protein |
PROTP78417-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: Several polymorphisms in the coding regions of the human GSTO1 have been identified. A polymorphism causing an alanine-to-aspartate (A140D) substitution in amino acid 140 produces a variant with lowered enzyme activities in the arsenic biotransformation.;GSTO1 Variant Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 241 amino acids fragment (1-241) having a total molecular mass of 36kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. ;The GSTO1 is purified by proprietary chromatographic techniques. |
IFN omega, Interferon omega, human |
RC217-20 |
Bio Basic |
100ug |
EUR 203.56 |
|
Glutathione S-Transferase omega 1 (Recombinant) |
20-abx073642 |
Abbexa |
-
EUR 393.60
-
EUR 6674.40
-
EUR 276.00
|
|
|
Glutathione S-Transferase omega 2 (Recombinant) |
20-abx073801 |
Abbexa |
-
EUR 393.60
-
EUR 7676.40
-
EUR 276.00
|
|
|
IFN omega, Human |
E34M082H |
EnoGene |
20 μg |
EUR 155 |
IFN Omega antibody |
70R-49896 |
Fitzgerald |
100 ul |
EUR 292.8 |
Description: Purified Polyclonal IFN Omega antibody |
IFN omega Antibody |
20-abx009126 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
IFN omega Antibody |
E38PA1577 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Recombinant Triticum monococcum Omega-gliadin |
AP72975 |
SAB |
each |
Ask for price |
|
Recombinant Triticum monococcum Omega-gliadin |
AP71150 |
SAB |
1mg |
EUR 2826 |
|
Recombinant Human Phylloquinone omega-hydroxylase CYP4F11 Protein, His-SUMO, E.coli-100ug |
QP8115-ec-100ug |
EnQuireBio |
100ug |
EUR 489.6 |
Recombinant Human Phylloquinone omega-hydroxylase CYP4F11 Protein, His-SUMO, E.coli-10ug |
QP8115-ec-10ug |
EnQuireBio |
10ug |
EUR 240 |
Recombinant Human Phylloquinone omega-hydroxylase CYP4F11 Protein, His-SUMO, E.coli-1mg |
QP8115-ec-1mg |
EnQuireBio |
1mg |
EUR 1958.4 |
Recombinant Human Phylloquinone omega-hydroxylase CYP4F11 Protein, His-SUMO, E.coli-200ug |
QP8115-ec-200ug |
EnQuireBio |
200ug |
EUR 760.8 |
Recombinant Human Phylloquinone omega-hydroxylase CYP4F11 Protein, His-SUMO, E.coli-500ug |
QP8115-ec-500ug |
EnQuireBio |
500ug |
EUR 1272 |
Recombinant Human Phylloquinone omega-hydroxylase CYP4F11 Protein, His-SUMO, E.coli-50ug |
QP8115-ec-50ug |
EnQuireBio |
50ug |
EUR 315.6 |
Recombinant Triticum aestivum Omega-5 gliadin,partial |
RPC22273-100ug |
Biomatik Corporation |
100ug |
EUR 889.9 |
Recombinant Triticum aestivum Omega-5 gliadin,partial |
RPC22273-1mg |
Biomatik Corporation |
1mg |
EUR 3237 |
Recombinant Triticum aestivum Omega-5 gliadin,partial |
RPC22273-20ug |
Biomatik Corporation |
20ug |
EUR 448.1 |
Recombinant Triticum aestivum Omega-5 gliadin, partial |
CSB-EP2020TQN |
Cusabio |
2541 mg |
Ask for price |
Recombinant Corynephage omega Diphtheria toxin,partial |
RPC27672-100ug |
Biomatik Corporation |
100ug |
EUR 801.9 |
Recombinant Corynephage omega Diphtheria toxin,partial |
RPC27672-1mg |
Biomatik Corporation |
1mg |
EUR 2885.2 |
Recombinant Corynephage omega Diphtheria toxin,partial |
RPC27672-20ug |
Biomatik Corporation |
20ug |
EUR 448.1 |
Recombinant Corynephage omega Diphtheria toxin, partial |
CSB-EP360420CQS |
Cusabio |
7389 mg |
Ask for price |
Glutathione S transferase Omega 1 recombinant monoclonal antibody |
A5850 |
Bimake |
100ul X 3 |
EUR 714 |
|
Description: A recombinant monoclonal antibody from rabbit against human Glutathione S transferase Omega 1 for WB, IHC,ELISA |
Recombinant Triticum monococcum Omega-gliadin,partial |
RPC25258-100ug |
Biomatik Corporation |
100ug |
EUR 1007.6 |
Recombinant Triticum monococcum Omega-gliadin,partial |
RPC25258-20ug |
Biomatik Corporation |
20ug |
EUR 479.6 |
Recombinant Triticum monococcum Omega-gliadin,partial |
RPC22752-100ug |
Biomatik Corporation |
100ug |
EUR 889.9 |
Recombinant Triticum monococcum Omega-gliadin,partial |
RPC22752-1mg |
Biomatik Corporation |
1mg |
EUR 3237 |
Recombinant Triticum monococcum Omega-gliadin,partial |
RPC22752-20ug |
Biomatik Corporation |
20ug |
EUR 448.1 |
Recombinant Hadronyche versuta Omega-hexatoxin-Hv1a |
CSB-EP347842HAD |
Cusabio |
3154 mg |
Ask for price |
Recombinant Triticum monococcum Omega-gliadin, partial |
CSB-EP360898TKR |
Cusabio |
3349 mg |
Ask for price |
Recombinant Triticum monococcum Omega-gliadin, partial |
CSB-YP360898TKR |
Cusabio |
6375 mg |
Ask for price |
Recombinant Hadronyche versuta Omega-hexatoxin-Hv1a |
AP73256 |
SAB |
1mg |
EUR 2826 |
|
Recombinant Triticum aestivum Omega-5 gliadinImported ,partial |
AP74216 |
SAB |
1mg |
EUR 2826 |
|
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU41679-100ug |
Biomatik Corporation |
100ug |
EUR 596.2 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU41679-1mg |
Biomatik Corporation |
1mg |
EUR 2642.9 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU41679-50ug |
Biomatik Corporation |
50ug |
EUR 479.6 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU54505-100ug |
Biomatik Corporation |
100ug |
EUR 603.9 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU54505-1mg |
Biomatik Corporation |
1mg |
EUR 2675.4 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU54505-50ug |
Biomatik Corporation |
50ug |
EUR 485.1 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU56773-100ug |
Biomatik Corporation |
100ug |
EUR 470.4 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU56773-1mg |
Biomatik Corporation |
1mg |
EUR 2184 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPU56773-50ug |
Biomatik Corporation |
50ug |
EUR 385 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
4-RPA623Hu01 |
Cloud-Clone |
-
EUR 640.39
-
EUR 295.20
-
EUR 2071.49
-
EUR 770.50
-
EUR 1420.99
-
EUR 504.00
-
EUR 4998.72
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Glutathione S Transferase Omega 1 expressed in: E.coli |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
4-RPA623Mu01 |
Cloud-Clone |
-
EUR 646.85
-
EUR 296.40
-
EUR 2095.68
-
EUR 778.56
-
EUR 1437.12
-
EUR 508.80
-
EUR 5059.20
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Glutathione S Transferase Omega 1 expressed in: E.coli |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPA623Hu01 |
Cloud-Clone |
10ug |
EUR 194 |
Recombinant Glutathione S Transferase Omega 1 (GSTo1) |
RPA623Mu01 |
Cloud-Clone |
10ug |
EUR 196 |
Recombinant Human Glutathione S-Transferase Omega 1 |
7-02905 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human Glutathione S-Transferase Omega 1 |
7-02906 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human Glutathione S-Transferase Omega 1 |
7-02907 |
CHI Scientific |
1mg |
Ask for price |
Glutathione S-Transferase omega 1 Mutant (Recombinant) |
20-abx073643 |
Abbexa |
-
EUR 393.60
-
EUR 6674.40
-
EUR 276.00
|
|
|
Recombinant Phoneutria nigriventer Omega-ctenitoxin-Pn3a |
CSB-EP305462EUV |
Cusabio |
9360 mg |
Ask for price |
IFN omega Blocking Peptide |
20-abx062771 |
Abbexa |
|
|
|
IFN-y Recombinant Protein |
40-557 |
ProSci |
0.1 mg |
EUR 481.2 |
Description: IFN-γ is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-γ receptors are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-γ stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-γ species-specific and is biologically active only in human and primate cells. Recombinant human IFN-γ is a 16.7 kDa protein containing 143 amino acid residues.Manufactured using all non-animal reagents. |
IFN beta Recombinant Protein |
40-278-0005mg |
ProSci |
0.005 mg |
EUR 311.1 |
Description: Proteins of this family play an important role in inducing non-specific resistance against a broad range of viral infections. They also affect cell proliferation and modulate immune responses. Produced by peripheral blood leukocytes and lymphoblastoid cells, IFNα is an acid stable molecule that signals through IFNα/βR, which is also used by IFNβ. Both IFNs have similar anti-viral activity and regulate expression of MHC class I antigens. IFNα contains four highly conserved cysteine residues which form two disulfide bonds, one of which is necessary for biological activity. Recombinant human IFNβ is an 20.0 kDa protein containing 166 amino acid residues. Due to glycosylation, IFNβ has an approximate MW of 22.3 kDa based on SDS-PAGE gel and Mass Spectrometry. |
IFN beta Recombinant Protein |
40-278-002mg |
ProSci |
0.02 mg |
EUR 437.1 |
Description: Proteins of this family play an important role in inducing non-specific resistance against a broad range of viral infections. They also affect cell proliferation and modulate immune responses. Produced by peripheral blood leukocytes and lymphoblastoid cells, IFNα is an acid stable molecule that signals through IFNα/βR, which is also used by IFNβ. Both IFNs have similar anti-viral activity and regulate expression of MHC class I antigens. IFNα contains four highly conserved cysteine residues which form two disulfide bonds, one of which is necessary for biological activity. Recombinant human IFNβ is an 20.0 kDa protein containing 166 amino acid residues. Due to glycosylation, IFNβ has an approximate MW of 22.3 kDa based on SDS-PAGE gel and Mass Spectrometry. |
Recombinant Human Glutathione S-Transferase Omega 1 Mutant |
7-02908 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Human Glutathione S-Transferase Omega 1 Mutant |
7-02909 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Human Glutathione S-Transferase Omega 1 Mutant |
7-02910 |
CHI Scientific |
1mg |
Ask for price |
IFN gamma Recombinant Protein |
40-277-002mg |
ProSci |
0.02 mg |
EUR 311.1 |
Description: IFN-γ is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-γ receptors are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-γ stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-γ species-specific and is biologically active only in human and primate cells. Recombinant human IFN-γ is a 16.7 kDa protein containing 143 amino acid residues. |
IFN gamma Recombinant Protein |
40-277-01mg |
ProSci |
0.1 mg |
EUR 437.1 |
Description: IFN-γ is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-γ receptors are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-γ stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-γ species-specific and is biologically active only in human and primate cells. Recombinant human IFN-γ is a 16.7 kDa protein containing 143 amino acid residues. |
IFN gamma Recombinant Protein |
40-449-002mg |
ProSci |
0.02 mg |
EUR 311.1 |
Description: IFN-gamma is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-gamma receptors are present in most immune cells, which respond to IFN-gamma signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-gamma signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulates the antigen-specific phases of the immune response. Additionally, IFN-gamma stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-gamma species-specific and is biologically active only in human and primate cells. Recombinant murine IFN-gamma is a 15.6 kDa protein containing 134 amino acid residues. |
IFN gamma Recombinant Protein |
40-449-01mg |
ProSci |
0.1 mg |
EUR 437.1 |
Description: IFN-gamma is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-gamma receptors are present in most immune cells, which respond to IFN-gamma signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-gamma signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulates the antigen-specific phases of the immune response. Additionally, IFN-gamma stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-gamma species-specific and is biologically active only in human and primate cells. Recombinant murine IFN-gamma is a 15.6 kDa protein containing 134 amino acid residues. |
IFN gamma Recombinant Protein |
40-472-002mg |
ProSci |
0.02 mg |
EUR 311.1 |
Description: IFN-gamma is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-gamma receptors are present in most immune cells, which respond to IFN-gamma signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-gamma signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-gamma stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-gamma is species-specific and is biologically active only in human and primate cells. Recombinant rat IFN-gamma is a 15.6 kDa protein containing 135 amino acid residues. |
IFN gamma Recombinant Protein |
40-472-01mg |
ProSci |
0.1 mg |
EUR 437.1 |
Description: IFN-gamma is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-gamma receptors are present in most immune cells, which respond to IFN-gamma signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-gamma signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-gamma stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-gamma is species-specific and is biologically active only in human and primate cells. Recombinant rat IFN-gamma is a 15.6 kDa protein containing 135 amino acid residues. |
IFN gamma Recombinant Protein |
91-012 |
ProSci |
0.05 mg |
EUR 374.1 |
Description: IFN gamma is the major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease. Interferon gamma is produced mainly byT-cells and natural killer cells activated by antigens, mitogens, or alloantigens. It is produced by lymphocytes expressing the surface antigens CD4 and CD8. IFN gamma synthesis is induced by IL-2, FGF-basic, and EGF. |
IFN alpha Recombinant Protein |
91-329 |
ProSci |
0.05 mg |
EUR 556.8 |
Description: The Interferon- alpha/ beta Receptor 1 (IFN- alpha/ beta R1) is a receptor which binds Type I Interferons including Interferon- alpha and - beta . It is a cell surface receptor and heteromeric receptor composed of one chain with two subunits referred to as IFNAR1 and IFNAR2. IFN- alpha/ beta R1, in association with IFN- alpha/ beta R2, is required for propagating antiviral signal transduction triggered by IFN- alpha and IFN- beta . IFN- alpha/ beta R1 interacts very weakly or not at all with type 1 interferons and does not stably interact with IFN- alpha/ beta R2. Ligands associate with IFN- alpha/ beta R2, and this complex subsequently forms a stable ternary assembly with IFN- alpha/ beta R1. IFN- alpha/ beta R1 also associates with IFN- gamma R2 even in the absence of IFN- gamma stimulation. Human IFN- alpha/ beta R1 contains a nuclear localization signal in its extracellular domain that is required for receptor translocation to the nucleus following interaction with ligand. Interferon stimulation results in an immunologic response that is especially associated with viruses. |
IFN alpha Recombinant Protein |
91-431 |
ProSci |
0.05 mg |
EUR 556.8 |
Description: Interferon alpha/ beta Receptor 2 (IFN- alpha/ beta R2) is a single-pass type I membrane protein which belongs to the type II cytokine receptor family. It complexes with IFN- alpha/ beta R1 to form the signaling receptor complex for the family of alpha and beta IFN subtypes. By alternative splicing, IFN- alpha/ beta R2 can exist as a secreted soluble protein or as a type I membrane protein. IFN- alpha/ beta R2 is the principal ligand binding subunit of the receptor. Ligand binding is stabilized by the subsequent association with IFN- alpha/ beta R1, resulting in the formation of a signaling ternary receptor complex. IFNAR2 was detected in most lymphocytes, monocytes, and granulocytes, although IFNAR2 expression was higher in the monocytes and granulocytes than in the lymphocytes. Among the lymphocyte subsets, IFNAR2 showed high expression in natural killer (NK) cells and low expression in T lymphocytes. Isoform 1 and isoform 3 of IFNAR2 are directly involved in signal transduction due to their interaction with the TYR kinase, JAK1. Isoform 1 also interacts with the transcriptional factors, STAT1 and STAT2. Both forms are potent inhibitors of type I IFN activity. |
IFN gamma Recombinant Protein |
91-591 |
ProSci |
0.05 mg |
EUR 374.1 |
Description: Mouse Ifng is a secreted protein which belongs to the type I I (or gamma) interferon family. IFNG is produced by lymphocytes and activated by specific antigens or mitogens. In addition to having antiviral activity, IFNG also has important immunoregulatory functions. It is a potent activator of macrophages and has antiproliferative effects on transformed cells. It can potentiate the antiviral and antitumor effects of the type I interferons. Genetic variation in IFNG is associated with the risk of aplastic anemia (AA) which is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis. |
IFN alpha Recombinant Protein |
91-885 |
ProSci |
0.05 mg |
EUR 588.3 |
Description: Interferon alpha/ beta Receptor 2 (IFN- alpha/ beta R2) is a single-pass type I membrane protein which belongs to the type II cytokine receptor family. It complexes with IFN- alpha/ beta R1 to form the signaling receptor complex for the family of alpha and beta IFN subtypes. By alternative splicing, IFN- alpha/ beta R2 can exist as a secreted soluble protein or as a type I membrane protein. IFN- alpha/ beta R2 is the principal ligand binding subunit of the receptor. Ligand binding is stabilized by the subsequent association with IFN- alpha/ beta R1, resulting in the formation of a signaling ternary receptor complex. IFNAR2 was detected in most lymphocytes, monocytes, and granulocytes, although IFNAR2 expression was higher in the monocytes and granulocytes than in the lymphocytes. Among the lymphocyte subsets, IFNAR2 showed high expression in natural killer (NK) cells and low expression in T lymphocytes. Isoform 1 and isoform 3 of IFNAR2 are directly involved in signal transduction due to their interaction with the TYR kinase, JAK1. Isoform 1 also interacts with the transcriptional factors, STAT1 and STAT2. Both forms are potent inhibitors of type I IFN activity. |
IFN gamma Recombinant Protein |
92-362 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: IFN gamma is the major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease. Interferon gamma is produced mainly byT-cells and natural killer cells activated by antigens, mitogens, or alloantigens. It is produced by lymphocytes expressing the surface antigens CD4 and CD8. IFN gamma synthesis is induced by IL-2, FGF-basic, and EGF. |
IFN gamma Recombinant Protein |
92-632 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: Mouse Ifng is a secreted protein which belongs to the type I I (or gamma) interferon family. IFNG is produced by lymphocytes and activated by specific antigens or mitogens. In addition to having antiviral activity, IFNG also has important immunoregulatory functions. It is a potent activator of macrophages and has antiproliferative effects on transformed cells. It can potentiate the antiviral and antitumor effects of the type I interferons. Genetic variation in IFNG is associated with the risk of aplastic anemia (AA) which is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis. |
IFN gamma Recombinant Protein |
92-633 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: Mouse Ifng is a secreted protein which belongs to the type I I (or gamma) interferon family. IFNG is produced by lymphocytes and activated by specific antigens or mitogens. In addition to having antiviral activity, IFNG also has important immunoregulatory functions. It is a potent activator of macrophages and has antiproliferative effects on transformed cells. It can potentiate the antiviral and antitumor effects of the type I interferons. Genetic variation in IFNG is associated with the risk of aplastic anemia (AA) which is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis. |
IFN-b IFN Beta Mouse Recombinant Protein, His Tag |
PROTP01575 |
BosterBio |
Regular: 25ug |
EUR 380.4 |
Description: IFN beta Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 182 amino acids (22-182 a.a.) and having a molecular mass of 22 kDa. Mouse IFN beta is fused to 20 amino acid at N-terminus and purified by proprietary chromatographic techniques. |
IFN lamda 2 Recombinant Protein |
40-279-0005mg |
ProSci |
0.005 mg |
EUR 311.1 |
Description: IFN-λ-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-lambdas uses a distinct receptor system composed of an IFN-λR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces anti-viral defense similar but distinct than the type I Interferons.(Kotenko, SV. et al. Nat Immunology 2003 [1] p. 69-77). Recombinant human IFN-λ 2 is a 19.6 kDa protein containing 174 amino acid residues. |
IFN lamda 2 Recombinant Protein |
40-279-002mg |
ProSci |
0.02 mg |
EUR 437.1 |
Description: IFN-λ-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-lambdas uses a distinct receptor system composed of an IFN-λR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces anti-viral defense similar but distinct than the type I Interferons.(Kotenko, SV. et al. Nat Immunology 2003 [1] p. 69-77). Recombinant human IFN-λ 2 is a 19.6 kDa protein containing 174 amino acid residues. |
IFN lamda 1 Recombinant Protein |
40-280-0005mg |
ProSci |
0.005 mg |
EUR 311.1 |
Description: IFN λ-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-lambdas use a distinct receptor system composed of an IFN-λR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces anti-viral defense similar but distinct than the type I Interferons. (Kotenko, SV. et al. Nat Immunology 2003 [1] p. 69-77). Recombinant human IFN-λ 1 is a 19.8 kDa protein containing 178 amino acid residues. |
IFN lamda 1 Recombinant Protein |
40-280-002mg |
ProSci |
0.02 mg |
EUR 437.1 |
Description: IFN λ-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-lambdas use a distinct receptor system composed of an IFN-λR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces anti-viral defense similar but distinct than the type I Interferons. (Kotenko, SV. et al. Nat Immunology 2003 [1] p. 69-77). Recombinant human IFN-λ 1 is a 19.8 kDa protein containing 178 amino acid residues. |
IFN gamma R1 Recombinant Protein |
92-375 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: Interferon gamma receptor 1(IFNGR1) encoded by the IFNGR1 gene, is a single-pass type 1 membrane protein which belongs to the type II cytokine receptor family. IFNGR1 is phosphorylated at Ser/Thr residues after translation. IFNGR1 is a receptor for interferon gamma, two receptors bind one interferon gama dimer. A genetic variation in IFNGR1 is associated with susceptibility to Helicobacter pylori infection. In addition, defects in IFNGR1 are a cause of mendelian susceptibility to mycobacterial disease, also known as familial disseminated atypical mycobacterial infection. |
IFN gamma R1 Recombinant Protein |
92-538 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: The tetrameric receptor complex for IFN gamma consists of two subunits, IFNGR1 (IFN gamma R alpha) and IFNGR2 (IFN gamma R beta ), through which the dimeric IFN- gamma exerts its biological functions, including antiviral, antiproliferation and immune-modulatory activity in mammals. Both IFNGR1 and IFNGR2 are single transmembrane proteins belonging to the class II cytokine family. FNGR1, widely expressed in most host cells, is essential for IFN gamma binding, receptor trafficking, and signal transduction. IFNGR1 possesses an intracellular Janus tyrosine kinase (JAK) 1 binding site, a signal transducer and activator of transcription 1 (STAT1) binding site. The resulting STAT1 homodimers translocate from the cytoplasm to the nucleus and bind to the interferon-gamma activated sequence (GAS) promoter to induce expression of downstream interferon stimulated genes (ISGs). |
IFN gamma R1 Recombinant Protein |
92-539 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: The tetrameric receptor complex for IFN gamma consists of two subunits, IFNGR1 (IFN gamma R alpha) and IFNGR2 (IFN gamma R beta ), through which the dimeric IFN- gamma exerts its biological functions, including antiviral, antiproliferation and immune-modulatory activity in mammals. Both IFNGR1 and IFNGR2 are single transmembrane proteins belonging to the class II cytokine family. FNGR1, widely expressed in most host cells, is essential for IFN gamma binding, receptor trafficking, and signal transduction. IFNGR1 possesses an intracellular Janus tyrosine kinase (JAK) 1 binding site, a signal transducer and activator of transcription 1 (STAT1) binding site. The resulting STAT1 homodimers translocate from the cytoplasm to the nucleus and bind to the interferon-gamma activated sequence (GAS) promoter to induce expression of downstream interferon stimulated genes (ISGs). |
IFN lambda 2 Recombinant Protein |
40-444-0005mg |
ProSci |
0.005 mg |
EUR 311.1 |
Description: IFN lambda-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-lambdas uses a distinct receptor system composed of an IFN-lambdaR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces anti-viral defense similar but distinct than the type I Interferons. Recombinant murine IFN-lambda2 is a 19.8 kDa protein containing 175 amino acid residues. |
IFN lambda 2 Recombinant Protein |
40-444-002mg |
ProSci |
0.02 mg |
EUR 437.1 |
Description: IFN lambda-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-lambdas uses a distinct receptor system composed of an IFN-lambdaR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces anti-viral defense similar but distinct than the type I Interferons. Recombinant murine IFN-lambda2 is a 19.8 kDa protein containing 175 amino acid residues. |
IFN alpha-6 Recombinant Protein |
91-559 |
ProSci |
0.05 mg |
EUR 821.4 |
Description: Interferon alpha-6 (IFN- alpha6) is a secreted protein which belongs to the alpha/ beta interferon family. IFN- alpha6 is produced by macrophages, expressed at low level, only 1.0% of the average gene in this release. IFN- alpha6 contains interferon alpha, beta and delta domain. IFN- alpha has antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. |
IFN alpha-4 Recombinant Protein |
91-822 |
ProSci |
0.05 mg |
EUR 588.3 |
Description: Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. They allow for communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors. They are typically divided among three IFN classes: Type I, Type II and Type III. IFNA4 is a secreted protein and produced by macrophages. Two variants of IFNA4 (IFNA4a and IFNA4b) are known, which differ from each other by changes in their coding regions at nucleotide positions 220 and 410 . |
IFN alpha-1 Recombinant Protein |
91-853 |
ProSci |
0.05 mg |
EUR 821.4 |
Description: Interferon alpha-1/13(IFN-alpha-1/13 for short), also known as Interferon alpha-D, is a secreted protein which belongs to the alpha/beta interferon family. It is produced by macrophages. IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. IFN-alpha exerts a variety of other biological effects, including antitumor and immunomodulatory activities and are increasingly used clinically to treat a range of malignancies, myelodysplasias and autoimmune diseases. |
IFN alpha-2 Recombinant Protein |
92-577 |
ProSci |
0.05 mg |
EUR 374.1 |
Description: At least 23 different variants of Interferon- alpha are known. The individual proteins have molecular masses between 19-26 kD and consist of proteins with lengths of 156-166 and 172 amino acids. All IFN- alpha subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN- alpha subtypes differ in their sequences at only one or two positions. Naturally occurring variants also include proteins truncated by 10 amino acids at the carboxyl-terminal end. |
IFN-alpha 1 Recombinant Protein |
11-192 |
ProSci |
0.1 mg |
EUR 714.3 |
Description: Interferon alpha-1 is also known as IFN-alpha-1/13, Interferon alpha-D, LeIF D and IFNA1, belongs to the alpha / beta interferon family. Interferons alpha-1 and alpha-13 have identical protein sequences. Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. IFN-alpha can either suppress or promote the development of autoimmune diabetes. It is likely that IFN-alpha plays a complex role in the etiology of type 1 diabetes. |
IFN-alpha 1 Recombinant Protein |
11-193 |
ProSci |
0.1 mg |
EUR 714.3 |
Description: Interferon alpha-1 is also known as IFN-alpha-1/13, Interferon alpha-D, LeIF D and IFNA1, belongs to the alpha / beta interferon family. Interferons alpha-1 and alpha-13 have identical protein sequences. Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. IFN-alpha can either suppress or promote the development of autoimmune diabetes. It is likely that IFN-alpha plays a complex role in the etiology of type 1 diabetes. |
IFN alpha-2b Recombinant Protein |
91-004 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: At least 23 different variants of IFN- alpha are known. The individual proteins have molecular masses between 19-26 kDa and consist of proteins with lengths of 156-166 and 172 amino acids. All IFN- alpha subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN- alpha subtypes differ in their sequences by only one or two positions. Naturally occurring variants also include proteins that are truncated by 10 amino acids at the carboxyl-terminal end. |
IFN alpha-2a Recombinant Protein |
91-018 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: At least 23 different variants of IFN- alpha are known. The individual proteins have molecular masses between 19-26 kDa and consist of proteins with lengths of 156-166 and 172 amino acids. All IFN- alpha subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN- alpha subtypes only differ in their sequences by one or two positions. Naturally occurring variants also include proteins truncated by 10 amino acids at the carboxy-terminal end. |
IFN-gamma R1 Recombinant Protein |
96-889 |
ProSci |
0.2 mg |
EUR 651.3 |
Description: Interferon gamma receptor 1 (IFNGR1) is also known as CD antigen CD119, which belongs to the type II cytokine receptor family. IFNGR1 contains two fibronectin type-III domains and two Ig-like C2-type (immunoglobulin-like) domains. IFNGR1 / CD119 is receptor for interferon gamma. Two receptors bind one interferon gamma (IFNG) dimer. |
Mouse IFN beta Recombinant Protein |
R02041-2 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN beta is a mammalian Type I inferferon, functionig as a regulator of cellular activity by interacting with cell-surface receptors and activating various signaling pathways. IFN beta produces antiviral, antibacterial, and anticancer properties. Mouse IFN beta Recombinant Protein is purified IFN beta produced in yeast. |
Swine IFN beta Recombinant Protein |
R02041-3 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN beta is a mammalian Type I interferon, functioning as a regulator of cellular activity by interacting with cell-surface receptors and activating various signaling pathways. IFN beta produces antiviral, antibacterial, and anticancer properties. Swine IFN beta Recombinant Protein is purified IFN beta produced in yeast. |
Swine IFN gamma Recombinant Protein |
R00393-11 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Swine IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Human IFN gamma Recombinant Protein |
R00393-7 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Human IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Mouse IFN gamma Recombinant Protein |
R00393-8 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Mouse IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Ovine IFN gamma Recombinant Protein |
R00393-9 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Ovine IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Bovine IFN beta Recombinant Protein |
R02041 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN beta is a mammalian Type I inferferon, functionig as a regulator of cellular activity by interacting with cell-surface receptors and activating various signaling pathways. IFN beta produces antiviral, antibacterial, and anticancer properties. Bovine IFN beta Recombinant Protein is purified IFN beta produced in yeast. |
Bovine IFN gamma Recombinant Protein |
R00393-1 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Bovine IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Rabbit IFN gamma Recombinant Protein |
R00393-10 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Rabbit IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Canine IFN gamma Recombinant Protein |
R00393-2 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Canine IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Equine IFN gamma Recombinant Protein |
R00393-5 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Equine IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Feline IFN gamma Recombinant Protein |
R00393-6 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Feline IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Canine IFN alpha Recombinant Protein |
R09608-1 |
BosterBio |
5ug/vial |
EUR 310.8 |
Description: IFN alpha is a mammalian Type I inferferon, mainly involved in innate immune response against viral infection. Canine IFN alpha Recombinant Protein is purified IFN alpha produced in yeast. |
The species Minoa murinata (Scopoli, 1763) sensu lato is examined all through its distribution vary. Specimens from central Europe (Germany, Italy, France) are in contrast with these from Serbia, Croatia, Slovenia and newly collected specimens from jap Turkey, Armenia, Georgia and Russia. The research is predicated on a mixture of behavioural observations, morphological characters (measurement, wing coloration, construction of female and male genitalia) in addition to genetic knowledge (DNA barcoding). Morphological research of the populations from jap Turkey, Armenia, Georgia and Russia verify the taxon Minoa murinata f./ssp. lutea Schwingenschuss, 1954 as a bona species. It is herewith upgraded from synonymy of M. murinata to species degree. The outcomes of DNA barcoding are mentioned. Wing sample, female and male genitalia of each species are illustrated.